Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Jun;182(6):2673-2681.
doi: 10.1007/s00431-023-04944-y. Epub 2023 Mar 31.

Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis

Sho Tashiro  1 , Takayuki Mihara  1 , Rikiya Okawa  1 , Yoko Tanaka  1 , Masaru Samura  1 , Yuki Enoki  2 , Kazuaki Taguchi  1 , Kazuaki Matsumoto  1 , Yuka Yamagishi  3
Affiliations
Meta-Analysis

Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis

Sho Tashiro et al. Eur J Pediatr. 2023 Jun.

Abstract

We conducted a systematic review and meta-analysis to examine the efficacy profiles of metronidazole (MNZ) and vancomycin (VCM) in pediatric and adolescent patients with Clostridioides difficile infection (CDI). A systematic review and meta-analysis was conducted using four electronic databases (PubMed, Cochrane Library, Web of Science, and Clinicaltrials.gov) through July 6, 2022. We analyzed the clinical cure and recurrence rates to determine the efficacy of MNZ and VCM. The clinical cure rates in all included studies were not significantly different between MNZ and VCM (OR = 0.63; 95% CI = 0.36-1.10; I2 = 0%; P = 0.10). Subgroup analyses were performed separately for each region to account for regional differences in the CDI. MNZ treatment achieved significantly lower clinical cure rates than did VCM in the United States of America (USA) and Europe (OR = 0.42, 95% CI = 0.19-0.93, I2 = 0%, P = 0.03). Recurrence rates were not significantly different between MNZ and VCM (OR = 1.48, 95% CI = 0.62-3.53, I2 = 28%, P = 0.38). Conclusion: MNZ exhibited significantly lower clinical cure rates than did VCM in the US and Europe; therefore, it is not recommended for the management of CDI in pediatric and adolescent populations. What is Known: • The unavailability of robust data on recommendations of therapeutic agents for the management of Clostridioides difficile infections in children precludes effective antibiotic choice. What is New: • Metronidazole exhibited significantly lower clinical cure rates than did vancomycin in the United States of America and Europe and recurrence rate was not significantly different between metronidazole and vancomycin; therefore, it is not recommended for the management of Clostridioides difficile infection in children.

Keywords: Clostridioides difficile infection; Metronidazole; Pediatric and adolescent populations; Systematic review and meta-analysis; Vancomycin.

PubMed Disclaimer

References

    1. Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP et al (2021) Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 73:e1029–e1044. https://doi.org/10.1093/cid/ciab549 - DOI - PubMed
    1. van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B et al (2021) European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27:S1–S21. https://doi.org/10.1016/j.cmi.2021.09.038 - DOI - PubMed
    1. Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D et al (2014) Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: Results from two multinational, randomized, controlled trials. Clin Infect Dis 59:345–354. https://doi.org/10.1093/cid/ciu313 - DOI - PubMed
    1. Krutova M, de Meij TGJ, Fitzpatrick F, Drew RJ, Wilcox MH, Kuijper EJ (2022) How to: Clostridioides difficile infection in children. Clin Microbiol Infect 28:1085–1090. https://doi.org/10.1016/j.cmi.2022.03.001 - DOI - PubMed
    1. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66:987–994. https://doi.org/10.1093/cid/ciy149 - DOI - PubMed

LinkOut - more resources